Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05492266 · ClinicalTrials.gov registry record · NA

Expiratory Muscle Strength Training for Hypernasal Speech in Children

A NA study of Velopharyngeal Insufficiency and Velopharyngeal Incompetence Due to Cleft Palate, sponsored by Noel Jabbour.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05492266 is a NA study of Velopharyngeal Insufficiency and Velopharyngeal Incompetence Due to Cleft Palate that is actively recruiting participants, run by Noel Jabbour. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05492266, a NA study of Velopharyngeal Insufficiency and Velopharyngeal Incompetence Due to Cleft Palate, is actively recruiting participants, sponsored by Noel Jabbour.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

When the soft palate does not move enough because of a cleft palate or for unknown reasons, this can lead to a speech difference called velopharyngeal insufficiency. The purpose of this research study is to test if soft palate exercises using a hand help breathing device will help improve the ability of the soft palate to close the area between the throat and nose and help improve speech.

Interventions

  • DEVICE Expiratory Muscle Strength Training
  • DEVICE Maintenance Training

Study Locations (1)

Pennsylvania

  • UPMC Children's Hospital of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-03-03
Est. Completion 2027-11
Phase NA

Sponsor

Noel Jabbour

2 total trials

What the Registry Record Tells You About NCT05492266

The ClinicalTrials.gov registry entry for NCT05492266 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Noel Jabbour, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Velopharyngeal Insufficiency appearing as the primary indexed condition, and to 2 interventions - of which Expiratory Muscle Strength Training is the first listed.

NCT05492266 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05492266 about?

NCT05492266 is a clinical study titled "Expiratory Muscle Strength Training for Hypernasal Speech in Children". When the soft palate does not move enough because of a cleft palate or for unknown reasons, this can lead to a speech difference called velopharyngeal insufficiency. The purpose of this research study is to test if soft palate exercises using a hand help breathing device will help improve the abilit...

What is the current status of trial NCT05492266?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-03-03. Estimated completion is 2027-11.

What conditions does trial NCT05492266 study?

This clinical trial studies the following conditions: Velopharyngeal Insufficiency, Velopharyngeal Incompetence Due to Cleft Palate, Inadequate Velopharyngeal Closure, Palatopharyngeal Incompetence, Hypernasality.

What interventions are being tested in trial NCT05492266?

The interventions under investigation include: Expiratory Muscle Strength Training (DEVICE), Maintenance Training (DEVICE).

Who is sponsoring clinical trial NCT05492266?

This trial is sponsored by Noel Jabbour, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05492266 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Velopharyngeal Insufficiency

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.